US 11279934
Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
granted A61PA61P27/02A61P35/00
Quick answer
US patent 11279934 (Methods for treating cancer using nucleic acids targeting MDM2 or MYCN) held by Phio Pharmaceuticals Corp. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Phio Pharmaceuticals Corp.
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P27/02, A61P35/00